Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 2, 1999, Pages 600-607

  Olschewski, Horst ^a   Ghofrani, H Ardeschir ^a   Walmrath, Dieter ^a   Schermuly, Ralph ^a   Temmesfeld Wollbrück, Bettina ^a   Grimminger, Friedrich ^a   Seeger, Werner ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FELODIPINE; ILOPROST; METHYLPREDNISOLONE; PROSTACYCLIN;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FIBROSIS; LUNG GAS EXCHANGE; LUNG VASCULAR RESISTANCE; LUNG VENTILATION PERFUSION RATIO; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASODILATATION;

EID: 0032810972     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.2.9810008     Document Type: Article

References (22)

1. 1. Lee, P., P. Langevitz, C. A. Alderdice, M. Aubrey, P. A. Baer, M. Baron, D. Buskila, J. P. Dutz, I. Khonstanteen, S. Piper, M. Ramsden, T. O. Rosenbach, S. Sukenik, S. Wilkinson, and E. C. Keystone. 1992. Mortality in systemic sclerosis (scleroderma). Q. J. Med. 82:139-148.
2. 2. Barst, R. J., L. J. Rubin, M. D. McGoon, E. J. Caldwell, W. A. Long, and P. S. Levy. 1994. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann. Intern. Med. 121: 409-415.
3. 3. Barst, R. J., L. J. Rubin, W. A. Long, M. D. McGoon, S. Rich, D. B. Badesch, B. M. Groves, V. F. Tapson, R. C. Bourge, B. H. Brundage, S. K. Koerner, D. Langleben, C. A. Keller, S. Murali, B. F. Uretsky, L. M. Clayton, M. M. Jöbsis, S. D. Blackburn, D. Shortino, and J. W. Crow. 1996. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N. Engl. J. Med. 334:296-301.
4. 4. Rubin, L. J. 1997. Primary pulmonary hypertension. N. Engl. J. Med. 336:111-117.
5. 5. Agusti, A. G. N., and R. Rodriguez-Roisin. 1993. Effect of pulmonary hypertension on gas exchange. Eur. Respir. J. 6:1371-1377.
6. 6. Kinsella, J. P., S. R. Neish, E. Shaffer, and S. H. Abman. 1992. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:819-820.
7. 7. Roberts, J. D., D. M. Polaner, P. Lang, and W. M. Zapol. 1992. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:818-819.
8. 8. Neonatal Inhaled Nitric Oxide Study Group. 1997. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N. Engl. J. Med. 336:597-604.
9. 9. Roberts, J. D., J. R. Fineman, W. M. Zapol, F. C. Morin, III, P. W. Shaul, S. Rimar, M. D. Schreiber, R. A. Polin, M. S. Zwass, M. M. Zayek, I. Gross, M. A. Heymann, J. Briegel, M. Welte, and K. Peter. 1997. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N. Engl. J. Med. 336:605-610.
10. 10. Rossaint, R., K. J. Falke, F. López, K. Slama, U. Pison, and W. M. Zapol. 1993. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328:399-405.
11. 11. Williamson, D. J., C. Hayward, P. Rogers, L. L. Wallman, A. D. Sturgess, R. Penny, and P. S. Macdonald. 1996. Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension. Circulation 94:477-482.
12. 12. Walmrath, D., T. Schneider, J. Pilch, F. Grimminger, and W. Seeger. 1993. Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 342:961-962.
13. 13. Walmrath, D., T. Schneider, R. Schermuly, H. Olschewski, F. Grimminger, and W. Seeger. 1996. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 153:991-996.
14. 2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur. Surg. Res. 25:329-340.
15. 15. Walmrath, D., T. Schneider, J. Pilch, R. Schermuly, F. Grimminger, and W. Seeger. 1995. Effects of aerosolized prostacyclin in severe pneumonia. Impact of fibrosis. Am. J. Respir. Crit. Care Med. 151:724-730.
16. 16. Zwissler, B., G. Kemming, O. Habler, M. Kleen, M. Merkel, M. Haller, J. Briegel, M. Welte, and K. Peter. 1996. Inhaled prostacyclin versus inhaled nitric oxide in adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154:1671-1677.
17. 17. Olschewski, H., D. Walmrath, R. Schermuly, H. A. Ghofrani, F. Grimminger, and W. Seeger. 1996. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann. Intern. Med. 124:820-824.
18. 18. Sitbon, O., F. Brenot, A. Denjean, A. Bergeron, F. Parent, and R. Azarian. 1995. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 151: 384-389.
19. 19. Warren, J. B., and T. Higenbottam. 1996. Caution with the use of inhaled NO. Lancet 348:629.
20. 20. Wagner, P. D., H. A. Saltzman, and J. B. West. 1974. Measurement of continuous distributions of ventilation-perfusion ratios: theory. J. Appl. Physiol. 36:588-599.
21. 21. Miller, O., S. Tang, A. Keech, and D. Celermajer. 1995. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet 346:51-52.
22. 22. Pepke-Zaba, J., T. W. Higenbottam, A. T. Ding-Xuan, D. Stone, and J. Wallwork. 1991. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338:1173-1174.